Literature DB >> 4545164

Twp populations of T lymphocytes immune to the lymphocytic choriomeningitis virus.

M Volkert, O Marker, K Bro-Jorgensen.   

Abstract

In this report seven different parameters were employed to investigate the spleen and lymph node cells from mice at the early and the late state of immunity to the lymphocytic choriomeningitis (LCM) virus. Distinct differences were observed. Morphological studies revealed a different size distribution of the cells in the preparations from the early and the late state of immunity. The cell mixtures of early immune cells contained many more large and blast-like lymphoid cells than the other. Where the cell function was concerned, the cytotoxic activity against LCM virus-infected target cells was almost entirely a function of the early immune cells, and our data strongly indicate that enhancement does not play any role for the disappearance by time of this cell activity. The antiviral effect after transfer to acutely infected animals was also predominantly a function of the early immune cells and the same was the case concerning the ability to protect against a lethal acute infection. However, the early immune cells were almost inactive after transfer to chronically infected virus carriers, whereas transplants of late immune cells to such mice had a very strong antiviral effect. The resistance to X irradiation also varied. Even high X-ray doses could not destroy the function of early immune cells, whereas the function of the late immune cells was readily impaired by X-ray treatment. The early and the late immune cells have one thing in common-both are susceptible to treatment with anti-theta serum. Because of the differences observed between the early and the late immune cells, it is concluded that they belong to different cell populations. However, because of the common susceptibility to anti-theta serum, probably both populations are T-cell lymphocytes. The implications of the results and the role of the different cells in the combat of the viral infection are discussed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4545164      PMCID: PMC2139666          DOI: 10.1084/jem.139.5.1329

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease.

Authors:  G A Cole; N Nathanson; R A Prendergast
Journal:  Nature       Date:  1972-08-11       Impact factor: 49.962

2.  Thymus-derived lymphocytes: humoral and cellular reactions distinguished by hydrocortisone.

Authors:  S Segal; I R Cohen; M Feldman
Journal:  Science       Date:  1972-03-10       Impact factor: 47.728

3.  Functional heterogeneity of murine lymphoid cells. 3. Differential responsiveness of T cells to phytohemagglutinin and concanavalin A as a probe for T cell subsets.

Authors:  J D Stobo; W E Paul
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

4.  Antiviral action of immune lymphocytes in mice infected with lymphocytic choriomeningitis virus.

Authors:  C A Mims; R V Blanden
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

Review 5.  Immunological tolerance to viruses.

Authors:  M Volkert; J H Larsen
Journal:  Prog Med Virol       Date:  1965

6.  The occurrence of tow types of cytotoxic lymphoid cells in mice immunised with allogeneic tumour cells.

Authors:  S Denham; C K Grant; J G Hall; P Alexander
Journal:  Transplantation       Date:  1970-04       Impact factor: 4.939

7.  Separation of stages in the development of the "T" cells involved in cell-mediated immunity.

Authors:  K Shortman; K T Brunner; J C Cerottini
Journal:  J Exp Med       Date:  1972-06-01       Impact factor: 14.307

8.  Synergy among lymphoid cells mediating the graft-versus-host response. 3. Evidence for interaction between two types of thymus-derived cells.

Authors:  H Cantor; R Asofsky
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

9.  Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers.

Authors:  D H Gilden; G A Cole; N Nathanson
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

10.  Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice.

Authors:  D H Gilden; G A Cole; A A Monjan; N Nathanson
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

View more
  17 in total

1.  The activity of T and B lymphocytes in immunity and tolerance to the lymphocytic choriomeningitis virus in mice.

Authors:  M Volkert; K Bro-Jorgensen; O Marker; B Rubin; L Trier
Journal:  Immunology       Date:  1975-09       Impact factor: 7.397

2.  Pronounced virus-dependent activation drives exhaustion but sustains IFN-γ transcript levels.

Authors:  Kathryn J Mackerness; Maureen A Cox; Lauren M Lilly; Casey T Weaver; Laurie E Harrington; Allan J Zajac
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

3.  T lymphocyte function as the principal target of lymphocytic choriomeningitis virus-induced immunosuppression.

Authors:  K Bro-Jorgensen; F Güttler; P N Jorgensen; M Volkert
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

4.  Cytotoxic T cell response to lymphocytic choriomeningitis virus. Properties of precursors of effector T cells, primary effector T cells and memory T cells in vitro and in vivo.

Authors:  M B Dunlop; P C Doherty; R M Zinkernagel; R V Blanden
Journal:  Immunology       Date:  1977-09       Impact factor: 7.397

5.  A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers.

Authors:  O Planz; S Ehl; E Furrer; E Horvath; M A Bründler; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

6.  Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response.

Authors:  D Moskophidis; S P Cobbold; H Waldmann; F Lehmann-Grube
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

Review 7.  Understanding memory CD8+ T cells.

Authors:  Tasleem Samji; Kamal M Khanna
Journal:  Immunol Lett       Date:  2017-03-06       Impact factor: 3.685

8.  A comparison between LCM virus-specific secondary cytotoxic T lymphocytes generated by Con A and by the homologous antigen.

Authors:  O Marker; G T Andersen
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

9.  The permeability of the blood-brain barrier in mice suffering from fatal lymphocytic choriomeningitis virus infection.

Authors:  O Marker; M H Nielsen; N H Diemer
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

Review 10.  Profile of a serial killer: cellular and molecular approaches to study individual cytotoxic T-cells following therapeutic vaccination.

Authors:  Emanuela M Iancu; Petra Baumgaertner; Sébastien Wieckowski; Daniel E Speiser; Nathalie Rufer
Journal:  J Biomed Biotechnol       Date:  2010-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.